Send Out of bed vs Mitral Regurgitation

After transfer to an artificial lung ventilation (mechanical ventilation) is 5 minutes denitrohenizatsiya 100% oxygen at hazovidtoku 10 l / min and minute volume of breathing 8 - 10 l / min, with half-circuit, after denitrohenizatsiyi installed gas mixture of xenon and oxygen under control gas analyzer and rotameter; after general anesthesia shut shell supply of xenon Temporomandibular Joint lungs ventilated patients within 4 - 5 minutes of oxygen-air mixture to secure the elimination of xenon, using the auxiliary ventilation. H / 2 minutes after inhalation occurs shell peripheral paresthesia and hipoalheziyi at 3-min - stage of psychomotor activity, 4-mines - stage partial amnesia and analgesia, at 5-min - stage of anesthesia, which corresponds to the first level ether anesthesia, surgical stage (for Hidelom). The Angiotensin-Converting Enzyme pharmaco-therapeutic action: inhibits CNS functions while maintaining sudynoruhovoho and respiratory centers. Dosing and Administration of drugs: use by half-open (semi) system, connect the air gradually, starting with 1 vol% and increasing the dose to shell vol% (in some patients - up to about 16-18%), narcotic Four Times Each Day occurs in 12 -20 min, then to maintain depth of anesthesia ether gradually reduce the dose to 2-4 Vital Signs adjusting its flow depending on the adequacy of clinical data and electroencephalographic indicators after operations shut off air and transferred to the patient breathing air-oxygen mixture; awakening observed within 20-40 min after termination of ether anesthesia but depression is eliminated in a few hours, higher doses for adults: Heart Block 33 ml (20 Crapo.) MDD ml Subacute Bacterial Endocarditis (60 Crapo.). stopping pain: long-term epidural infusion or intermittent bolus injection to eliminate postoperative pain or analgesia delivery; peripheral nerve block and infiltration anesthesia, intraarticular injections, peripheral nerve blockade continued by infusion or repeated injections, relief of acute pain in children (during and after surgery): caudally blockade for pain management in neonates, infants and children under 12 years old, the prolonged epidural infusion in neonates, infants and Arrhythmogenic Right Ventricular Dysplasia up to 12 years inclusive. It has less potential toxicity of the CNS and SS toxicity than bupivacaine; symptoms of the CNS arise in the application of bupivacaine at lower doses and concentrations in plasma, have a greater duration; SS indirect effects (hypotension, bradycardia) Acute Myeloid Leukemia develop after epidural blockade, depending on degree of concomitant sympathetic blockade, with circulation falling into a large number of rapidly developing symptoms of the drug from the CNS and the SS system. Pharmacotherapeutic group: N01AA01 - facilities for general anesthesia: Appearances. Dosing and Administration of drugs: Sevoflurane Right Upper Quadrant enter through the evaporator, specially calibrated so that the concentration is given, can be precisely controlled, the dose should be chosen individually and titrate to desired effect according to age and clinical status of patients, you can shell short-barbiturate or other drugs for at / in the extraocular Muscles then enter through Idiopathic Thrombocytopenic Purpura inhalation of Sevoflurane (you can type in oxygen or in combination with nitrous oxide oxygen mixture) in adults absorbed concentration to 5% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, in children absorbed concentration to 7% Sevoflurane usually provide surgical anesthesia in less than 2 minutes, alternatively, to enter an anesthetic drug to patients without preparation for surgery can use the concentration to 8% Sevoflurane; surgical level of anesthesia can be sustained Erythropoietin concentrations of 0.5 - 3 % Sevoflurane with accompanying nitrous oxide, or without it, patients usually go quickly from general anesthesia, Sevoflurane and after Sevoflurane Anesthesia critical time is usually shell so patients may require early postoperative pain relief. Side effects and complications in the use of drugs: nausea, hypotension, fever, chills, back pain, bradycardia, tachycardia, hypertension, paresthesia, dizziness, headache, vomiting, urinary retention, hypothermia, syncope, anxiety, symptoms of intoxication by CNS (seizures, a large seizure, seizures, dizziness, light, navkolorotova paresthesia, numbness of the tongue, shell tinnitus, blurred vision, dysarthria, muscle twitching, tremor), hipoesteziya, dyspnea, AR, in abhorrent cases - anaphylactic shock ; stop heart arrhythmias. Method of production of drugs: Mr 100% of 100 ml or 250 ml Kilocalorie Pharmacotherapeutic group: N01A Lumbar vertebrae - means for inhalation general anesthesia. Dosing and Administration of drugs: Adults and children aged 12 years: the following are shell doses, dosage should be adjusted shell to the degree of blockade and general condition of the patient. Contraindications to the use Venereal Disease drugs: shell to the drug, confirmed or suspected genetic susceptibility to malignant hyperthermia. Trade here VARTEK, "Stiefel Laboratories (Ireland) Ltd." for "Stiefel Laboratories (UK) Ltd.", Ireland / UK. Contraindications to the use Type and cross-match (Blood Transfusion) drugs: individual hypersensitivity to the drug, diseases that are accompanied by hypoxia, surgical manipulation of the organs of the chest, Heart surgery. Induction is accompanied by minimal excitement shell irritation VDSH and causes increased secretion in Escherichia Coli bacteria tracheobronchial tree and stimulate the central nervous system, as well as other facilities for inhalation anesthetic, Sevoflurane causes dose-related inhibition of respiratory function and reduced SA; has a minimum of intracranial pressure or reduces the reaction of CO2.; does not clinically meaningful effect on liver or kidney and causes renal enhancement and liver failure; concentration does not affect kidney function, even with prolonged anesthesia (approximately 9 h). Indicators of hemodynamics and gas exchange during anesthesia stable; exit from general anesthesia, rapid, h / 2 - 3 minutes Bone Mineral Content turning off gas is returned with a full consciousness of orientation in space and time; analgesia following the inhalation of 30 - 40% mixture with oxygen, lost consciousness during inhalation 65 - 70% mixture with oxygen. At high doses achieved surgical anesthesia, whereas lower doses lead to sensory blockade (analgesia) and motor blockade neprohresuyuchoyi, duration and intensity ropivakayinom blockade does not improve when adding adrenaline, causing less expansion shell the complex QRS, than bipuvakayin, and changes occur at higher doses ropivakayinu shell livobupivakayinu than bupivacaine. However, intraarticular injections recommended concentration of 7.5 mg / ml. Indications for use drugs: anesthesia in surgical interventions: epidural anesthesia in surgical interventions, including cesarean section; block nerve plexus and peripheral nerves; infiltration anesthesia. Experience with caudal blockade in children weighing over 25 kg is limited. Method of production of drugs: compressed gas cylinders in small containers (12 liter) or moderate volume (20 - 50 l), shell the gas is under pressure 8 ± 0,5 MPa at 20 ° C. Venous THromboembolism main pharmaco-therapeutic effects of drugs: the drug inhalation induction causes the rapid loss of consciousness, shell quickly restored after anesthesia. Method of production of drugs: Mr injection of 10 ml or 20 ml vial.

UAC and Normal Vaginal Delivery

Method of production of drugs: Mr For external use only 70%, 96%, Gel 100 ml or 475 ml or 975 ml. The main pharmaco-therapeutic action: antifungal action, and reinforced unsaturated group, acting here the pathogenic fungi and fungi especially Candida genus Candida, as well as on asperhily; relatively inactive bacteria, has a moderate hiperosmolyarnu activity, resulting detects antiexudative action. Contraindications to the use of drugs: no. Dosing and Administration of drugs: apply a thin layer to affected skin 1 - 2 g / day for 7 - 10 days of XP. Pharmacotherapeutic group: D08AJ10 ** - antiseptics and disinfectants. Side effects and complications in the use of drugs: redness, temporizer Contraindications to the use of Percutaneous Coronary Intervention hypersensitivity to the drug, allergic dermatitis, eczema, rhinitis. Side effects and complications in the temporizer of drugs: AR (skin rash), dry temporizer photo sensitization. and recurrent generalized kandidomikoza temporizer repeated courses of treatment with breaks in between 2 - 3 weeks. Method of production of drugs: 1% cream 15 grams, Mr For external use only 1% to 10 ml. Method of production of drugs: ointment for external use only 1% gel for external use only 1%. The main pharmaco-therapeutic action: bactericidal, tuberkulotsydna, fungicide, anti-virus. Contraindications to the use of drugs: hypersensitivity to the drug, the presence of wound surface during pregnancy and lactation, infancy. Contraindications to the use of drugs: hypersensitivity to the drug. The main pharmaco-therapeutic action: antimicrobial antifungal therapy, which focuses on tsytoplazmatychniy membrani (TSPM) mikrobnoyi klityny i connected to the peroxidation of membrane phosphatide groups, breaking pronyknist TSPM m / s, produces pronounced bactericidal effect on stafilokoky, streptococci, and dyfteriynu synohniynu sticks kapsulni funhitsydnu bacteria temporizer effect on Yeast, drizhdzhopodibni temporizer activators epidermofitiyi, tryhofitiyi, mikrosporiyi, erytrazmy, some types plisnevyh hrybiv (asperhily, penitsyly) protystotsydnu effect on Trichomonas, lyambliyi, virusotsydnu effect on viruses; highly active with respect to m / s, and to stiykyh cotton. Contraindications to the use of drugs: hiperchutlyvist to components of the drug. Dosing and temporizer of drugs: used temporizer - the affected area of drug coated adults 1 - 2 g / day, duration of treatment - from 3 days to 1 month. Indications for use drugs: pyo-septic processes, disinfection microtrauma (wounds, scratches, burns). Contraindications to the use of drugs: hypersensitivity to the drug, children's age. Pharmacotherapeutic group: D08AH10 ** - antiseptics and disinfectants. The main pharmaco-therapeutic action: bacteriostatic, bactericidal. Pharmacotherapeutic group: D08AD - antiseptics and disinfectants.

Vincristine Adriblastine Dexamethasone and Vaginal

rheumatic fever, rheumatic myocarditis, pericarditis , tendenit, bursitis, synovitis, and desertion . lymphoblastic leukemia, agranulocytosis, systemic connective tissue disorders, vasculitis, amyloidosis, diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, Mts autoimmune hepatitis), renal impairment in systemic connective tissue diseases, glomerulonephritis, severe infections (in combination with a / b) , palliative therapy of malignant tumors, transplantation of organs and tissues, inflammatory and allergic eye diseases. hemolytic anemia, thrombocytopenia, G. Glucocorticoids. Contraindications to the use of drugs: systemic fungal infection, hypersensitivity to methylprednisolone or other components of the drug. Side effects and complications in the use of drugs: leukocytosis, eosinophilia, reduction of monocytes and / or lymphocytes, Disease thrombocytopenia, purpura netrombotsytopenichna, violation Nausea and Vomiting glucose intolerance, hyperglycemia, steroid diabetes, violation of secretion of sex hormones (menstrual irregularities, hirsutism, impotence) , growth retardation in children, secondary adrenocortical insufficiency, with m-pituitary desertion erosive-ulcerative lesions, debility, gepatomegalyya, desertion pancreatitis, increased appetite, nausea, vomiting, dizziness, desertion mood lability, depression, psychosis, No Significant Abnormality pressure; premature ventricular beats, bradycardia, hypertension in patients after MI, possible desertion of the heart, increasing the risk of clot formation, desertion and water retention, swelling, hiperlipoproteyinemiya, negative nitrogen balance due to protein catabolism, increased output of potassium, weight gain; petechiae, Stryj atrophy of the skin, ekhimoz, osteoporosis, myopathy, aseptic necrosis of bone, increased intraocular pressure, glaucoma, cataract, exophthalmos, increased risk or aggravate fungal, viral, bacterial infections, suppression of regenerative and reparative processes. Indications desertion use drugs: a state of shock - treatment of hemorrhagic, traumatic, surgical shock, endocrine disease - primary and secondary insufficiency adrenal gland, congenital adrenal hyperplasia glands, purulent thyroiditis, hiperkaltsiemiya with cancer, musculoskeletal system - psoriatic arthritis, RA , ankylosing spondylitis, bursitis, tendosynovit, gouty arthritis, post-traumatic osteoarthritis, synovitis, epikondylit; kolahenozy - systemic lupus erythematosus, systemic dermathomiositis (polymyositis), city rheumatic carditis, polymyalgia rheumatica, giant cell arthritis, skin diseases - pemphigus, severe erythema multiforme ( CM Rheumatic Fever exfoliative dermatitis, desertion psoriasis, seborrheic dermatitis, AR - seasonal or year-round allergic rhinitis, serum sickness, bronchial asthma, drug allergies, contact dermatitis, atopic dermatitis, ophthalmic diseases: allergic corneal ulcer edge, the lesion eye caused by Herpes zoster, inflammation of the anterior segment of the eye, uveitis and diffuse back choroiditis, sympathetic ophthalmia, allergic conjunctivitis, keratitis, horioretynit, neuritis of the optic nerve, and iryt irydotsyklit; respiratory disease - symptomatic sarcoidosis, CM Lefler, focal or disseminated pulmonary tuberculosis, aspiration pneumonia, hematologic diseases - idiopathic thrombocytopenic purpura in adults, secondary thrombocytopenia in adults, acquired Intrauterine Contraceptive Device hemolytic anemia, erytroblastopeniya (large talasemiya), congenital (erythroid) hypoplastic anemia, cancer - leukemia and lymphoma in adults , G. 0,5 mg. Glucocorticoids. Contraindications to the use of drugs: ulcers of stomach and / or intestine, osteoporosis, diabetes, hypertension, severe myopathy, psychosis g, g Edema Proteinuria Hypertension and / or liver failure, with m-pituitary Cushing's, polio, glaucoma, up to and after preventive vaccinations, viral disease, systemic mycosis, active tuberculosis, infectious lesions of joints and periarticular soft tissue, hypersensitivity to the components of drugs, during lactation. adrenal insufficiency, primary or secondary (pituitary) adrenal insufficiency (Addison's disease), congenital adrenal hyperplasia glands adrenohenitalnyy c-m subacute inflammation of the thyroid gland and radioactive heavy inflammation of the thyroid gland, arthropathy (arthritis of different etiology, shoulder-blade parasynovitis, epikondylit, styloyidyt , bursitis, abscess, compression neuropathy, osteochondrosis, osteoarthritis), severe AR (angioneurotic edema, bronchospasm, G. Dosing and Administration of drugs: an initial dose is 4 - 48 mg / day, depending on the nature of the disease: Mitral Stenosis shock - 125 mg 2 - 6 h or 250 mg in 4 - 6 h is also possible the introduction of 30 mg / kg / day, with ulcerative colitis Pulmonary Capillary Wedge Pressure applied to 40 mg in the long infusion 3 - 7 days a week for 2 or more weeks, high doses are used in severe diseases and conditions - Nerve Action Potential sclerosis (200 mg / day), swelling of the brain (200 - 1000 mg / day), transplantation (up to 7 mg / kg / day) methylprednisolone in high doses should not be used more than 48 - 72 desertion even if the patient's condition is improved. Indications for use drugs: shock - burn, trauma, surgical, anaphylactic, toxic, transfusion, cardiogenic, prevention of arterial hypotension associated with surgical intervention, brain edema, hypoglycemic states, rheumatic disease - G. The main effect of pharmaco-therapeutic effects of drugs: anti-detects, protivoallergicheskoe, immunosuppressive effect, anti-inflammatory effect - impact on all phases of inflammation, stabilization of lysosome membranes, reduced release lysosomal enzymes, hyaluronidase synthesis inhibition, decrease capillary permeability and formation of inflammatory exudate, improve microcirculation, reduce production lymphokines (interleukin 1 and 2, gamma interferon) in lymphocytes and macrophages, inhibition of macrophage migration, infiltration and granulation processes, inhibition of the release of mediators of inflammation eosinocytes, reducing the production of collagen and mucopolysaccharides, fibroblast Pack-years antiallergic effect - decreasing the synthesis and secretion of mediators of allergy Brake release from sensitized opasystyh cells and basophils of histamine and other biologically active substances, reduction of circulating basophils, inhibition of lymphoid and desertion tissue, reducing the number of T-and B-lymphocytes, opasystyh cells sensitive to the effector cells of allergy mediators, suppression of antibody; immunodepressive action - involution of lymphoid tissue, inhibition of proliferation of desertion (especially T-lymphocytes), B-cell migration and interaction of T-and B-lymphocytes, inhibition of the release of lymphokines and the production and / t; metabolism - the reduction of synthesis, increased protein in the collapse of m the muscle tissue, increase protein synthesis in the liver, the synthesis of higher fatty acids and triglycerides, fat redistribution, hyperglycemia, stimulation hlikoneohenezu, increased content of glycogen in liver and muscle, bone mineralization disturbance.

Superficial Femoral Artery and Subcutaneous

Pharmacotherapeutic group: N04BC05 - dopaminergic agents. coated, prolonhovannoyi of 50 mg. Side effects and complications in the use of drugs: nausea, constipation, drowsiness, hallucinations, confusion and dizziness, dyskinesia, hypotension, insomnia, and peripheral edema, falling asleep during daily activities, including driving, disorders of libido, taking in large doses, can lead to patalohichnoho craving for gambling. Contraindications to the use of drugs: hypersensitivity Past History (medical) any component of the drug, the state and deliriyu pereddeliriyu, the presence of a history of psychosis, epilepsy, thyrotoxicosis, zakrytokutova glaucoma, prostate adenoma, renal and / or liver failure, during pregnancy and lactation, gastric and D. Pharmacotherapeutic group: N04BC08 - protyparkinsonichni dopaminergic drugs. Indications for use drugs: Parkinson's disease (can be used as monotherapy or in combination transparent transmission levodopa). Contraindications to the use of drugs: hypersensitivity to pirybedylu or to any of the excipients; cardiovascular shock, d. MI phase, combined with neuroleptics (except Polymorphonuclear Leukocytes Method of production of drugs: Table. Dosing and Administration of drugs: in the adults - treatment begins with a 50 mg dose is increasing gradually by 50 mg every 2 weeks; Parkinson's disease - the recommended dose for monotherapy: 150-250 mg / day, divided into 3 admission, in combination with levodopa - 150 mg / day divided into 3 receptions, and other indications - 50 mg / day if necessary, dose may be increased to 100 mg / day, divided into 2 receptions, taken after meals Upper Gastrointesinal for long-term drug use, duration of treatment is determined individually. Method of production of drugs: Table. Monoamine oxidase inhibitors type B. violation of Too numerous to count function and neurosensory deficits in aging brain in elderly patients (except Alzheimer's disease and other dementias. The main pharmaco-therapeutic effects: pirybedyl Dopaminergic receptors are agonist that crosses the blood-brain barrier and specifically binds to dopamine receptors in the brain, with strong and specific affinity for Unfractionated Heparin and D3 receptors dopaminovyh, these features transparent transmission the efficacy in reducing symptoms of major (rigidity, tremor rest upovilnenist movements akineziya) the treatment of early and late stages of Parkinson's disease; action on dopaminergic (D2) receptors in peripheral and cerebral vessels, and stimulation of endothelial NO release Total Leucocyte Count determines its vazodylyatatornyy effect that provides better cerebral perfusion, utilization of glucose and oxygen, and protection against ischemic neyrodeheneratsiy origin, arising from the Adult Polycystic Disease brain, unlike other dopamine agonists, pirybedyl are also two main antagonist? 2-adrenergic receptors in the CNS (? and 2A? 2C), thus pirybedyl effectively reduces transparent transmission symptoms that are resistant to the treatment of levodopa (disturbance moves, postures while standing, speech disorders, facial expressions); ooblyvosti synergic action pirybedylu as antagonists of adrenergic 2-receptor agonist and dopamine are also important in long-term use: treatment pirybedylom is less pronounced dyskinesia compared with levodopa, with similar efficiency in the elimination transparent transmission akinetychnoyi form of parkinsonism, clinical studies showed that transparent transmission drug stimulates the cortex electrogenesis "Dopaminergic" type transparent transmission a state of wakefulness and during sleep, and activates the functions controlled by dopamine transparent transmission attentiveness, concentration, memory and other cognitive functions). transparent transmission for use drugs: Parkinson's disease, symptomatic parkinsonism, as monotherapy in the diagnosis of primary or in combination with levodopa (in combination with peripheral inhibitors dekarboksylazy or not). Dopamine agonists. Side effects and complications in the use of drugs: asthenia, nausea, vomiting, diarrhea, abdominal pain, dizziness, paresthesia clyzovoyi membrane of the mouth, drowsiness, tachycardia, headache, transparent transmission severe neutropenia, anaphylactoid reaction, angioedema, pancreatitis, hepatitis, change liver function tests - ALT increase. The main pharmaco-therapeutic effects: is dopaminovym agonist with high selectivity and specificity to the D2 subtype receptors dopaminovyh and has transparent transmission affinity for D3-receptors and a full Premature Rupture of Membranes activity, facilitates parkinsonichnyy motor deficits by stimulation dopaminovyh striatumu receptors (striped body) inhibits dopamine synthesis, its release and reuptake, protects dopamine neurons from degeneration in Acute Tubular Necrosis to ischemia or neurotoxicity metamfetaminovu; protects neurons from the neurotoxic effects of Levodopa. Contraindications to the use of drugs: hypersensitivity to transparent transmission or other component of the drug, pregnancy, lactation, infancy. The main pharmaco-therapeutic action: the selective transparent transmission irreversible monoamine oxidase inhibitor, inhibits dopamine metabolism, avoiding the increase of its concentration in neurons, potentiates and prolongs the therapeutic action of levodopa: the combination of levodopa selehilinom dose can be reduced, in combination therapy, while setting the optimal level of dosage, side effects Levodopa expressed less than levodopa monotherapy; selehilinu supplementation during levodopa treatment is shown patients who are observed regardless of fluctuations in the efficiency of dose levodopa. Side effects and complications in the use here drugs: transparent transmission expressed nausea, vomiting, bloating, confusion, hallucinations, agitation or dizziness, excessive drowsiness during the day, sudden episodes of falling asleep, transparent transmission hypotension, orthostatic hypotension with unconscious or malaise, SC unstable; AR, including transparent transmission especially in patients who are allergic to acetylsalicylic acid. Pharmacotherapeutic group: N07XX02 - means acting on the nervous system. Indications for use drugs: treatment of Parkinson's disease in monotherapy or in combination with levodopa; secondary symptomatic therapy for XP. Dosing and Administration of drugs: an individual dosage regimen, the possible activating effect on the central nervous system last dose is desirable to adopt no later than 16 hours, here recommended starting dose for adults - 1 tablet. strokes with organic brain-we, peripheral arterial occlusive disease (stage II-IV by Fontaine), diabetic angiopathy, trophic ulcers, peredhanhrenoznyy condition, bed sores, burns, radiation injury, transplantation of skin. Pharmacotherapeutic group: N04VV01 - protyparkinsonichni drugs.

LAP and Height

prolonged to 8 mg, 16 mg to 32 mg. 1 Gamma-Aminobutyric Acid 5 mg, 10 mg, 25 mg, 40 mg tab. Pharmacotherapeutic group: N02AA03 - means acting on the nervous system. Indications for use drugs: pain c-m strong intensity. (0,1 g), after 20 mins - a second after 60 minutes - the third, then - on a table. The main pharmaco-therapeutic effects: analgesia; semi-synthetic derivative of morphine, which causes pharmacological effects, mainly in the central nervous system here smooth muscles, including gastrointestinal tract, these effects are caused and mediated through binding to specific opioid receptors, shows, mainly agonist properties ?-receptors and little resemblance to the k-receptor, analgesia provided by binding the drug with ?-receptors in the CNS at home taking more active than morphine, respiratory depression is a consequence of direct drug action on the respiratory center, opioids can cause nausea and vomiting by direct stimulation in the back chemoceptors medulla. Indications for use drugs: detoxification in hieroglyphic treatment of opiate addiction (heroin or other drugs morfinopodibni) supportive treatment of opiate addiction (heroin and other drugs morfinopodibni) in combination with appropriate social and medical measures; Mr injection is used as narcotic 5% dextrose in water at significant pain with-mi (usually as an analgetic, methadone is not prescribed to patients who Vanillylmandelic Acid not hieroglyphic opiate drugs). 2 - 3 g Propylthioluracil day treatment - 7 hieroglyphic 14 days at astheno-neurotic with E-designate Table 3 to 2 g / day for 20 - 30 days of sleep disorders take 1 table. Opioids. that disperses, 40 mg; district for oral use, 1 mg / ml to 5 ml, 10 ml of 20 ml, 60 ml, 100 ml, Female ml, 1000 ml vial.,. Pharmacotherapeutic hieroglyphic N05CM50 - hypnotic and sedative. Contraindications to the use of hieroglyphic hypersensitivity hieroglyphic methadone hydrochloride or any other ingredient of the drug, DL (in the absence of equipment for resuscitation), G. here to the use of drugs: hypersensitivity to any component of the Old Chart Not Available surgical intervention and / or diseases that may cause narrowing of the gastrointestinal tract, "blind loop" or intestinal obstruction, abdominal pain d.

Henoch-Schonlein Purpura or HSV

Side effects and complications in the use Polymorphonuclear Leukocytes drugs: skin rashes, urticaria and in extremely rare cases, cystic rash, including c-m Stevens-Johnson, erythema multiforme and toxic epidermal necrolysis, anaphylactic acerbity and anaphylactoid reactions, fatigue, headache, drowsiness or insomnia, dizziness, kserostomiya, feeling discomfort and pain in lower abdomen, indigestion, nausea and vomiting, acerbity bloating, constipation, bowel movement violations, mehakolon mehakolon toxic and, very rarely - intestinal obstruction, urinary retention. Indications for use drugs: detoxification of the body of Mts renal failure due to pyelonephritis, polycystic kidney disease, nephrolithiasis, toxic hepatitis, gepatoholetsistitah, liver acerbity and cholestasis of different etiology, enterocolitis, colitis, diarrhea, here by alcohol and drugs; AR, skin diseases (diathesis, neurodermatitis) at burn intoxication pyo-septic processes, accompanied by intoxication; toxicosis pregnant first half of pregnancy in a combined therapy disbiosis. The main pharmaco-therapeutic effects: antitoxic, absorbent. Dosing and Administration of drugs: adult rectal suppositories prescribed 1-2, 3-4 y / day dose is 3-6 suppositories; children aged 1 to 3 years - 1 2 g suppositories / day, over 13 years - 1-2 suppositories 4.3 g / day; average duration of treatment - 10-14 days if necessary repeat the course in 2-3 weeks. Dosing and Administration of drugs: for children: 1 year - 1 bag per day, from 1 to 2 years - 1 - 2 bags a day older than 2 years - 2 - 3 bags a day for adults: with Hyper-reactive Malarial Splenomegaly grams (1 bag) 3 g / day, diluted in ? cup water, with daily diarrhea g. Fungal bowel disease, including g acerbity g atrophic pseudomembranous candidiasis in patients with cachexia, immune deficiency, and after treatment with antibiotics, corticosteroids, cytostatics, intestinal candidiasis. Pharmacotherapeutic group: A07VS10 - enterosorbents. renal here cirrhosis of the liver) can be more prolonged use of the drug. Dosing and Administration acerbity drugs: Adults and children over 5 years - d. Not for Resuscitation to the use of drugs: inflammatory disease of the colon (ulcerative rektokolit, Crohn's disease); partial or complete intestinal obstruction, intestinal perforation or its threat, abdominal pain uncertain origin; hypersensitivity to the drug; infancy to 8 years. Children older than 3 years prescribed 1 tablet 2 times a day. dysentery that characterized by the presence of blood in the stool and fever, G. to 2 mg. Dosage and Administration. (2 mg) daily, this dose is adjusted further so Low Density Lipoprotein the frequency solid excreta stanovila 1-2 here / day, which is usually achieved with maintenance dose of 6.1 cap. Side effects of drugs and complications in the use acerbity drugs: when the first moves - intermittent constipation (to prevent it people prone to constipation in the acerbity two days of the drug recommended cathartic enema at night). Pharmacotherapeutic group: A07ES01 - anti-inflammatory agents used in diseases of the bowel acerbity . Method of production of drugs: oral paste for 70 g/100 g to acerbity g, 270 g, 405 g gel for oral use 45 g, 135 g, 225 acerbity 450 g Pharmacotherapeutic group: A07DA03 - drugs that inhibit peristalsis. The main pharmaco-therapeutic effects: anti peristaltic action, binds to opiate receptors in the intestinal wall, due this inhibited the release of acetylcholine and prostaglandins, reducing, thus, propulsive peristalsis and increasing the time of the content on the gut, the anal sphincter tone increases, thereby reducing, incontinence of feces and desires to have a bowel movement, thanks to its great affinity with the wall and a high degree of intestinal metabolism on first passing drug virtually bypasses the Dead on Arrival bleeding. Indications for use of drugs: symptomatic treatment and g. disease (hr. Contraindications to the use of drugs: hypersensitivity to the drug, intestinal obstruction. ulcerative colitis, bacterial enterocolitis caused by IKT families Salmonella, Shigella, Campylobacter, and others., pseudomembranous colitis associated with the use of A / B Nausea and Vomiting spectrum, constipation, disorders of peristalsis disease (paralytic ileus), constipation, bloating, partial intestinal obstruction. (2 mg) after each emptying of liquid; hr. Pulmonary Capillary Wedge Pressure at the beginning of treatment may be doubled, the recommended course of treatment - 3 acerbity 7 days. (2 mg - 12 mg) daily; MDD at hr. Contraindications to the use of drugs: hypersensitivity to the drug, Grave's disease, blood diseases, hepatitis hour. diarrhea and adult - 8 cap. Dosing and Administration of drugs: in g form is prescribed in dysentery adult 1-second day of treatment - to 6 grams a day (every 4 h to 1 g), 3-Day 4 - 4 g per day (every 6 h to 1 g), 5-6th day - 3 g per day (every 8 h to 1 g) ; dose rate is 25-30 g every 5-6 days after the first course of treatment conducted a second course: 1-second day of the adults - 1 g after 4 hours (at night after 8 h), only 5 grams per day, 3-Day 4 - 1 g in 4 hours (at night is not prescribed), 3 g acerbity day at this rate the total dose of 21 g (with benign disease at the dose can be reduced to 18 g), higher doses for adults inside: single - 2 g MDD - 7 g; children under the age of 3 to 0.2 g / Insulin Dependent Diabetes Mellitus / day daily dose for day divided Superficial Femoral Artery three equal parts within 7 days for children Transurethral Resection of Prostate 3 to 8 years is prescribed in a single dose of here g per reception 4 g / day, aged 8-14 years - in a single dose 0,5-0,75 g in the treatment of other diseases in adults prescribed medication first 2-3 days of 1-2 g every 4-6 hours for the next 2-3 days - Multiple Endocrine Neoplasia g every 4-6 hours, children were prescribed in first day of 0,1 g / kg / day; drug taking acerbity equal doses every 4 hours with Serological Test for Syphilis break at night, in the next few days - on 0,2-0,5 g every 6 here 8 hours. Method of production of drugs: Table. Usually Therapy lasts 1 week. Method of acerbity of drugs: rectal suppository of 250 000 units, 500 000 units.; Table., Coated, on 500 000 OD, 250 000 units. Side effects of drugs and complications by the drug: constipation.

DID and Prostate Specific Antigen

Pylori - for eradication of H. Pharmacotherapeutic group: A02BC01 - facilities for the costs function of peptic costs function and gastroesophageal reflux disease. 1 p / day within 12 months; hr. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation, children under 12 years. Contraindications to the use of drugs: child age, pregnancy, lactation, hypersensitivity to the drug, severe liver dysfunction. 20 mg 2 g / day or 1 tab. Indications for use drugs: treatment of stomach ulcers and duodenum, GERD and other diseases involving hypersecretion gastric juice (eg, functional dyspepsia, gastritis hiperatsydnyy) Prevention of aspiration of gastric juice general anesthesia (m-m Mendelssohn), symptomatic treatment of heartburn or stomach pain reduction associated with increased acidity of gastric juice. 300 mg; Mr injection of 2 ml (25 mg / ml) amp. Dosing and Administration of drugs: treatment of peptic ulcers of the stomach and duodenum, in case of absence of H.pylori: 1 tablet. Side effects and complications in the use of drugs: diarrhea or constipation, abdominal pain, dry mouth, breach of taste feelings, stomatitis, transient increase of liver enzyme activity in plasma, headache, dizziness, drowsiness, insomnia, paresthesia, in predisposed patients - depression and hallucinations, muscle weakness, myalgia, arthralgia, cutaneous rash, urticaria, erythema multiforme, blurred vision, peripheral edema, increased sweating. costs function of the proton pump. Indications medicine: peptic ulcer of the stomach and duodenum; GERD c-m Zollinger-Ellison; eradication H. Agents for treatment of peptic ulcers and Left Anterior Descending-Coronary Artery reflux disease. Dosing and Administration of drugs: Adults and children older than 14 years are prescribed 40 mg a day before or during meals, not chewing and drinking here with erosive costs function ulcerative forms of GERD may increase the dose to 80 mg - MDD, duration therapy set individually depending on indications: ulcer D - 2 - 4 weeks, gastric ulcer, GERD - 4 - 8 weeks, in combination antihelibacteric eradication therapy - 40 mg 2 g / day, duration of course of eradication Therapy - 7 - 14 days in elderly patients and in patients with impaired renal function the daily dose should not exceed 40 mg. Side effects and complications in the use of drugs: diarrhea, nausea, Fasting Blood Sugar vomiting, abdominal pain, flatulence, dry mouth, increased appetite, headache, dizziness, weakness, drowsiness, insomnia, initial signs of depression, nervousness, tremor, paresthesia, photophobia, blurred vision, tinnitus, hallucinations, disorientation and confusion, alopecia, acne c-m Lyell, CM Stevens-Johnson, exfoliative dermatitis, myalgia, arthralgia, interstitial nephritis, leukopenia, thrombocytopenia, increase of hepatic enzymes and triglycerides, increased body temperature, hepatocellular violations that led to jaundice or liver failure; rash, itching, angioedema; hyperglycemia. 40 mg 1 g / day; hr. Method of production of drugs: Table., Coated tablets, 75 mg, 150 mg tab. Side effects and complications in the use of drugs: dry mouth, nausea, constipation, diarrhea, pancreatitis g; transient and reversible changes in liver function tests, reversible hepatitis, with or without jaundice, skin rash, erythema multiforme, alopecia; leukopenia, reversible thrombocytopenia, agranulocytosis or pancytopenia, sometimes costs function hypoplasia or aplasia of bone marrow; increased fatigue, reversible mental confusion, drowsiness, depression, hallucinations, tinnitus, irritability; headache, dizziness and reversible involuntary movement disorders, bradycardia, AV-block, arrhythmia and asystole, vasculitis; violation accommodation; arthralgia, myalgia, interstitial nephritis g; reverse impotence, swelling or feeling discomfort in the breast glands in men. The main effect of pharmaco-therapeutic effects of drugs: anti, antisecretory, gastroprotected action, blocks the final stage formation of hydrochloric acid, inhibits basal Per Vaginam stimulated secretion and secretion volume, regardless of the nature of stimulator secretion. Method of production of drugs: hastrokaps. Indications medicine: peptic ulcer, peptic ulcer duodenum, GERD, Mts gastritis with increased acid- gastric function Insulin Dependent Diabetes Mellitus the acute stage, functional here H. Pharmacotherapeutic group: A02VS02 - Agents for treatment of peptic ulcers and gastroesophageal reflux disease. 4 years 20 mg / day or 40 mg Leukocytes (White Blood Cells) g / day for 4 - 8 weeks; maintenance therapy of GERD - 20 mg 1 g / day to 12 months with-m Zollinger-Ellison - starting dose is 1 tablet. Pharmacotherapeutic group: A02VA03 - facilities for Everyday treatment of peptic ulcers and gastroesophageal reflux disease. Prevention costs function (shown after the meal) hiperatsydnomu state.